Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Add shares to your
quickpicks to
display them here!

Futura Medical (FUM)

Price 33.70p on 19-07-2024 at 16:30:01
Change -0.05p -0.14%
Buy 35.50p
Sell 33.80p
Buy / Sell FUM Shares
Last Trade: Sell 139.00 at 33.8019p
Day's Volume: 261,933
Last Close: 34.65p
Open: 34.25p
ISIN: GB0033278473
Day's Range 33.60p - 34.85p
52wk Range: 24.10p - 57.00p
Market Capitalisation: £102m
VWAP: 34.16031p
Shares in Issue: 302m

Recent Trades History Futura Medical (FUM)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 139 33.8019p Ordinary
15:29:18 - 19-Jul-24
Buy* 2,901 34.208p Ordinary
15:15:26 - 19-Jul-24
Buy* 2,928 34.15p Ordinary
14:53:24 - 19-Jul-24
Buy* 2,915 34.30p SI Trade
14:33:27 - 19-Jul-24
Sell* 103 33.55p SI Trade
14:21:57 - 19-Jul-24
Unknown* 10,000 33.95p Ordinary
14:11:39 - 19-Jul-24
Buy* 4 34.40p SI Trade
13:59:18 - 19-Jul-24
Buy* 174 34.40p SI Trade
13:55:41 - 19-Jul-24
Sell* 10,000 33.75p Ordinary
13:24:05 - 19-Jul-24
Sell* 1,667 33.70p Automatic Execution
13:22:50 - 19-Jul-24

Share Price History for Futura Medical

Time period:
Date Open High Low Close Volume

Share News for Futura Medical

EARNINGS AND TRADING: Lords trading in line; Time Out trading ahead

20th Jun 2024 20:02

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

13th Jun 2024 16:05

Read More

Futura Medical hails results as erectile dysfunction drug drives sales

10th Apr 2024 10:49

(Alliance News) - Futura Medical PLC on Wednesday celebrated its "first set out meaningful revenues" in 2023, as sales for its erectile dysfunction treatment climbed. Read More

UK earnings, trading statements calendar - next 7 days

3rd Apr 2024 12:58

Read More

IN BRIEF: Futura Medical's Eroxon to soon be available on prescription

14th Feb 2024 09:24

Futura Medical PLC - Guildford, England-based pharmaceutical company focused on sexual health products - Confirms that lead product Eroxon will from March 1 be available on prescription in England and Wales for the treatment of erectile dysfunction. Eroxon is a gel-based treatment designed to help the user obtain an erection, and serves as an alternative for people who are unwilling or unable to use medications like Viagra. Eroxon has also been available without a prescription in UK pharmacies since March last year. Read More

FTSE 100 Latest

Login to your account

Forgot Password?

Not Registered